Andere Kunden interessierten sich auch für
![Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis]( "Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis")
Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis49,99 €![Addressing the Threat of Drug-Resistant Tuberculosis]( "Addressing the Threat of Drug-Resistant Tuberculosis")
Addressing the Threat of Drug-Resistant Tuberculosis61,99 €![The New Profile of Drug-Resistant Tuberculosis in Russia]( "The New Profile of Drug-Resistant Tuberculosis in Russia")
The New Profile of Drug-Resistant Tuberculosis in Russia43,99 €![The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa]( "The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa")
The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa53,99 €![Tuberculosis in the Workplace]( "Tuberculosis in the Workplace")
Tuberculosis in the Workplace75,99 €![Drug Resistant Tuberculosis: Practical guide for clinical management]( "Drug Resistant Tuberculosis: Practical guide for clinical management")
Drug Resistant Tuberculosis: Practical guide for clinical management93,99 €![Global Tuberculosis Report 2018]( "Global Tuberculosis Report 2018")
Global Tuberculosis Report 201866,99 €
"An estimated 8.8 million people fell ill with tuberculosis (TB) in 2010 and 1.4 million died from the disease. Although antibiotics to treat TB were developed in the 1950s and are effective against a majority of TB cases, resistance to these antibiotics has emerged over the years, resulting in the growing spread of multidrug-resistant (MDR) TB. Due to challenges in timely and accurate diagnosis of drug-resistant TB, length and tolerability of treatment regimens, and expense of second-line anti-TB drugs, effectively controlling the disease requires complex public health interventions. The IOM Forum on Drug Discovery, Development, and Translation held three international workshops to gather information from local experts around the world on the threat of drug resistant TB and how the challenges it presents can be met. Workshops were held in South Africa and Russia in 2010. The third workshop was held April 18-19, 2011, in New Delhi, India, in collaboration with the Indian National Science Academy and the Indian Council of Medical Research. The aim of the workshop was to highlight key challenges to controlling the spread of drug-resistant strains of TB in India and to discuss strategies for advancing and integrating local and international efforts to prevent and treat drug-resistant TB. This document summarizes the workshop."--Publisher's description.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.